Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
| Study Number Sort descending | Lead Group | Study Title | CIRB | Study Status | |
|---|---|---|---|---|---|
| URCC-19075 | NCORP-University of Rochester Cancer Center | Multi-center Randomized Controlled Phase II Trial to Treat Chemotherapy-Induced Peripheral Neuropathy (CIPN) | Cancer Prevention and Control CIRB | Available to Open | |
| URCC-19085 | NCORP-University of Rochester Cancer Center | Wireless Transcutaneous Electrical Nerve Stimulation (TENS) For Chemotherapy-Induced Peripheral Neuropathy: A Phase II Clinical Trial | Cancer Prevention and Control CIRB | Available to Open | |
| URCC-19178 | NCORP-University of Rochester Cancer Center | Optimizing Functional Outcomes of Older Cancer Survivors After Chemotherapy | Cancer Prevention and Control CIRB | Available to Open | |
| URCC-19185 | NCORP-University of Rochester Cancer Center | Multicenter Randomized Controlled Trial Comparing Brief Behavioral Therapy for Cancer Related Insomnia (BBT-CI) and Healthy Eating Education Learning (HEAL) | Cancer Prevention and Control CIRB | Available to Open | |
| URCC-21038 | NCORP-University of Rochester Cancer Center | Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 Immunotherapy in a Community Oncology Setting | Cancer Prevention and Control CIRB | Available to Open | |
| URCC-22053 | NCORP-University of Rochester Cancer Center | High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients | Cancer Prevention and Control CIRB | Available to Open | |
| URCC-22063 | NCORP-University of Rochester Cancer Center | LOTUS-CC: Longitudinal Observational Trial to Uncover Subtypes of Cancer Cachexia | Cancer Prevention and Control CIRB | Available to Open | |
| UWI20-00-01 | CP-CTNet_CLO-University of Wisconsin | A Phase II Trial of the Immunogenicity of a DNA Plasmid Based Vaccine (STEMVAC) Encoding Th1 Selective Epitopes from Five Antigens Associated With Breast Cancer Stem Cells (MDM2, YB1, SOX2, CDH3, CD105) in Participants with Early Stage Triple Negative Breast Cancer | Cancer Prevention and Control CIRB | Available to Open | |
| UWI20-04-01 | CP-CTNet_CLO-University of Wisconsin | A Dose Escalation Phase I Trial of the Safety and Immunogenicity of RG1-VLP, a Candidate Broadly Protective Vaccine for the Prevention of HPV-Associated Cancer | Cancer Prevention and Control CIRB | Available to Open | |
| UWI2014-03-01 | CP-CTNet_CLO-University of Wisconsin | A Phase I Trial of the Safety and Immunogenicity of a DNA Plasmid Based Vaccine (WOKVAC) Encoding Epitopes Derived from Three Breast Cancer Antigens (IGFBP-2, HER2, AND IGF-1R) in Patients with Breast Cancer | Cancer Prevention and Control CIRB | Available to Open |